T-cell therapy induced CMRs with no CRSJune 24, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Inhibitor exhibits activity in B- and T-cell NHLsJune 21, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
EC grants blinatumomab full approvalJune 21, 2018Leukemia, Myelodysplasia, TransplantationPharmacyALL
Combo proves ‘beneficial’ for ‘unfit’ CLL patientsJune 20, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Gene signature might identify patients at risk of CAR T-associated neurotoxicityJune 19, 2018Leukemia, Myelodysplasia, TransplantationALL
FDA places SB-generated CAR T-cell therapy on clinical holdJune 19, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAggressive Lymphomas
Quizartinib can prolong OS in rel/ref, FLT3-ITD AMLJune 18, 2018Leukemia, Myelodysplasia, TransplantationAML
